{"metadata": {"source": "pubchem", "title": "Fentanyl | C22H28N2O | CID 3345 - PubChem", "description": "Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3345", "drug": "Fentanyl", "cid": 3345, "char_count": 196495, "word_count": 26843, "doc_id": "doc_16", "num_chunks": 282, "chunk_id": "16::chunk_22", "document_index": 16, "latency_s": 1.657663699996192, "prompt_toks": 49722, "completion_toks": 89, "relevance_score": 0.49398836}, "content": "Drug: Fentanyl | cid: 3345\nSource: pubchem | Source description: Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    FDA Label\n\nEffentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. , , BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. , , Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer. ,\n\n7.2 Drug Classes\n\nBreast Feeding; Lactation; Milk, Human; Analgesics, Opioid; Narcotics; Anesthetics, Intravenous; Opiates\n\n7.3 Drug Transformations\n\nFentanyl has known transformation products that include Norfentanyl.\n\nS66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448\n\n7.4 FDA Medication Guides\n\n1 of 7\n\nView All\n\nDrug\n\nActive Ingredient\n\n\n                    Context: \n                    This excerpt provides detailed information regarding the FDA-approved label for Effentora, a fentanyl-based medication used to treat breakthrough cancer pain in opioid-tolerant adults, including its indications, drug classes, known transformation product Norfentanyl, and related medication guides. It is relevant to the comprehensive chemical and pharmacological data on fentanyl presented in the full document, highlighting clinical usage, drug transformations, and regulatory aspects essential for research and medical reference.\n                "}
{"metadata": {"source": "psychonaut", "title": "Fentanyl - PsychonautWiki", "description": "Fentanyl (also known as Fentanil and by the brand names Sublimaze,[2] Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl,[3] Abstral,[4] Lazanda[5] among others[6]) is a potent opioid substance of the anilidopiperidine class. It is a strong agonist at the μ-opioid receptors and approximately 40 to 50 times more potent than pharmaceutical grade (i.e. 100% pure) heroin[7][8] and roughly 80 to 100 times more potent than morphine.&#91;citation needed&#93;", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Fentanyl", "drug": "Fentanyl", "cid": 3345, "char_count": 24990, "word_count": 3519, "doc_id": "doc_75", "num_chunks": 35, "chunk_id": "75::chunk_11", "document_index": 75, "latency_s": 0.714153199995053, "prompt_toks": 6275, "completion_toks": 66, "relevance_score": 0.19713514}, "content": "Drug: Fentanyl | cid: 3345\nSource: psychonaut | Source description: Fentanyl (also known as Fentanil and by the brand names Sublimaze,[2] Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl,[3] Abstral,[4] Lazanda[5] among others[6]) is a potent opioid substance of the anilidopiperidine class. It is a strong agonist at the μ-opioid receptors and approximately 40 to 50 times more potent than pharmaceutical grade (i.e. 100% pure) heroin[7][8] and roughly 80 to 100 times more potent than morphine.&#91;citation needed&#93;\n\n                    Text: \n                    Pain relief - In comparison to other opiates, fentanyl can be described as a strong analgesic, providing relief even at non-recreational doses.\n\nPhysical euphoria - Fentanyl can be considered as less intense in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin). The sensation itself can be described as strong feelings of intense physical comfort, warmth and bliss which spread throughout the body.\n\nItchiness - Unlike other opioids, fentanyl presents very little itch response due to little to no amounts of released histamines.\n\n\n                    Context: \n                    This section provides detailed descriptions of fentanyl's subjective physical effects, including pain relief, physical euphoria, and itchiness, highlighting its potency and differences from other opioids. It is relevant for understanding the drug's effects profile, harm potential, and user experiences, essential for harm reduction and safety information within the comprehensive fentanyl overview.\n                "}
{"metadata": {"source": "psychonaut", "title": "Fentanyl - PsychonautWiki", "description": "Fentanyl (also known as Fentanil and by the brand names Sublimaze,[2] Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl,[3] Abstral,[4] Lazanda[5] among others[6]) is a potent opioid substance of the anilidopiperidine class. It is a strong agonist at the μ-opioid receptors and approximately 40 to 50 times more potent than pharmaceutical grade (i.e. 100% pure) heroin[7][8] and roughly 80 to 100 times more potent than morphine.&#91;citation needed&#93;", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Fentanyl", "drug": "Fentanyl", "cid": 3345, "char_count": 24990, "word_count": 3519, "doc_id": "doc_75", "num_chunks": 35, "chunk_id": "75::chunk_26", "document_index": 75, "latency_s": 1.170183199996245, "prompt_toks": 6408, "completion_toks": 51, "relevance_score": 0.08464395}, "content": "Drug: Fentanyl | cid: 3345\nSource: psychonaut | Source description: Fentanyl (also known as Fentanil and by the brand names Sublimaze,[2] Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl,[3] Abstral,[4] Lazanda[5] among others[6]) is a potent opioid substance of the anilidopiperidine class. It is a strong agonist at the μ-opioid receptors and approximately 40 to 50 times more potent than pharmaceutical grade (i.e. 100% pure) heroin[7][8] and roughly 80 to 100 times more potent than morphine.&#91;citation needed&#93;\n\n                    Text: \n                    MAOIs - Such as banisteriopsis caapi, syrian rue, phenelzine, selegiline, and moclobemide.[26]\n\nSerotonin releasers - Such as MDMA, 4-FA, methamphetamine, methylone and αMT.\n\nSSRIs - Such as citalopram and sertraline\n\nSNRIs - Such as tramadol and venlafaxine\n\n5-HTP\n\nLegal status\n\nAustria: Fentanyl is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich).[citation needed]\n\nAustralia: Fentanyl is placed under Schedule 8, meaning that it is available for medical use, but possession, production or supply of it is illegal without authority. [27]\n\nCanada: Fentanyl is a Schedule I drug in Canada's Controlled Drugs and Substance Act.[28]\n\nGermany: Fentanyl is a controlled substance under Anlage III of the BtMG. It can only be prescribed on a narcotic prescription form.[29]\n\nNetherlands: Fentanyl is a List I substance of the Opium Law.\n\n\n                    Context: \n                    This excerpt details important drug interactions and the legal status of fentanyl across various countries, providing critical information for harm reduction, safe use, and understanding the regulatory landscape highlighted within the broader discussion of fentanyl's risks, pharmacology, and legal control measures.\n                "}
